Mittie Doyle, Chief Medical Officer: Avalo Therapeutics AVTX Sell · Filed 05/19

Trade details

Type: Insider sale
Amount: $56,280
Shares · price: 3,000 sh · $18.76 a share
Held after: 3,622 sh
Stock: Avalo Therapeutics AVTX
Person: Mittie DoyleChief Medical Officer
Trade date: 26/05/15
Filed: 26/05/19
Days to filing: 4 days

Sold 45.3% of holdings

Share of holding sold: 45.3%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 04/15~06/14

Mittie Doyle's recent trades

Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$98.7K
5,037 sh
$98.7K
Filed 08/17
Traded 08/17
Mittie DoyleChief Medical Officer
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$12.4K
679 sh
$12.4K
Filed 08/10
Traded 08/10
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$26.1K
1,450 sh
$26.1K
Filed 06/25
Traded 06/23
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$10.9K
679 sh
$10.9K
Filed 06/01
Traded 05/28
Mittie DoyleChief Medical Officer
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$952.8K
44,944 sh
$952.8K
Filed 05/07
Traded 05/06